- Activation of the carboxypeptidase U (CPU, TAFIa, CPB2) system in patients with SARS-CoV-2 infection could contribute to COVID-19 hypofibrinolytic state and disease severity prognosis(2022)
Authors: Karen Claesen, Yani Sim, An Bracke, Michelle De bruyn, Emilie De Hert, Gwendolyn Vliegen, An Hotterbeekx, Alexandra Vujkovic, Lida van Petersen, Fien De Winter, et al.
Pages: 1 - 11
- Proline-specific peptidase activities (DPP4, PRCP, FAP and PREP) in plasma of hospitalized COVID-19 patients(2022)
Authors: An Bracke, Emilie De Hert, Michelle De bruyn, Karen Claesen, Gwendolyn Vliegen, Alexandra Vujkovic, Lida van Petersen, Fien De Winter, An Hotterbeekx, Isabel Brosius, et al.
Pages: 4 - 11
- Proteolytic cleavage of bioactive peptides and protease-activated receptors in acute and post-colitis(2021)
Authors: Michelle De bruyn, Hannah Ceuleers, Nikita Hanning, Maya Berg, Joris De Man, Paco Hulpiau, Cedric Hermans, Ulf-Hakan Stenman, Hannu Koistinen, Anne-Marie Lambeir, et al.
Number of pages: 26
- Local colonic administration of a serine protease inhibitor improves post-inflammatory visceral hypersensitivity in rats(2021)
Authors: Nikita Hanning, Michelle De bruyn, Hannah Ceuleers, Tim Boogaerts, Maya Berg, Annemieke Smet, Heiko Ulrik De Schepper, Jurgen Joossens, Alexander van Nuijs, Joris De Man, et al.
Number of pages: 21
- Newly developed serine protease inhibitors decrease visceral hypersensitivity in a post-inflammatory rat model for irritable bowel syndrome(2018)
Authors: Hannah Ceuleers, Nikita Hanning, Leen Heirbaut, Samuel Van Remoortel, Pieter Paula Frans Van Der Veken, Sven Francque, Michelle De bruyn, Anne-Marie Lambeir, Joris De Man, Jean-Pierre Timmermans, et al.
Pages: 3516 - 3533
